Latest News
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboration with Israeli-American medical technology company...
argenx secures FDA priority review for VYVGART in seronegative myasthenia gravis
13 January 2026 - European immunology company argenx SE (EBR & NASDAQ: ARGX) said on Tuesday that the US Food and Drug Administration has accepted for priority review a supplemental Biologics License Application for VYVGART IV (efgartigimod alfa-...
TetraScience collaborates with Thermo Fisher Scientific to accelerate scientific data and AI enablement
13 January 2026 - Scientific data and AI company TetraScience announced on Monday that it has formed a collaboration with life science and clinical research company Thermo Fisher Scientific Inc (NYSE:TMO).The partners aim to accelerate AI across biop...
Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas
13 January 2026 - Curasight A/S (CPH:CURAS), a Denmark-based clinical stage radiopharmaceutical company, on Monday reported encouraging preliminary data from the first patient dosed in the ongoing Phase 1 uTREAT clinical trial in patients with high-g...
Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA
13 January 2026 - Abbisko Therapeutics Co Ltd (HKEX:02256), a China-based, oncology-focused biopharmaceutical company, announced on Monday that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for its novel, orall...